Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Wound Healing - Discovery Of A New Therapeutic Strategy Against Hypertrophic Scarring

next article
13.05.2002

 


Wound healing appears generally a banal event, but in a certain proportion of cases it evolves inappropriately in hypertrophic scars resulting in skin and organ deformations. This is due to an excess of wound contraction, a phenomenon that generally helps to close the wound. Hypertrophic scarring is observed frequently in burned patients.


For the past 30 years, Professor Giulio Gabbiani and his team are interested in the role of myofibroblasts in wound contraction. Myofibroblasts, specialized fibroblasts neo expressing the protein alpha-smooth muscle actin, are instrumental in wound contraction during normal wound healing. Tissue shortening is then stabilized by synthesis of extracellular matrix, collagen in particular. More precisely, alpha-smooth muscle actin within myofibroblasts becomes organized in filamentous bundles, called stress fibers, that allow the retractile movement producing wound contraction. During hypertrophic scarring, skin deformations depend on the inappropriate action of these stress fibers that for unknown reasons persist even after the epithelialization of the wound.

The team of the University of Geneva has isolated a sequence of alpha-smooth muscle actin that once injected in isolated myofibroblasts inhibits their contraction. Moreover, the same sequence applied to an experimental wound diminishes significantly wound contraction and skin deformation. Based on these results Giulio Gabbiani and his team suggest that this alpha-smooth muscle actin sequence has a potential therapeutic activity. The pharmaceutical industry UCB-Bioproducts has patented this sequence and is working on the production of commercial preparation. The clinical tests should start approximately at the beginning of next year. This discovery is the outcome of a 30 year long research.

Giulio Gabbiani | Source: alphagalileo
Further information: www.unige.ch/presse/a10communiques.html

next article

More articles from Health and Medicine:

nachricht Towards Improved Immunotherapy
01.12.2008 | Elsevier

nachricht First trial in patients with a potential treatment of the incurable ALS muscle disease
01.12.2008 | VIB, the Flanders Institute for Biotechnology

B2B Search

Product / Service
Company / Organisation

Latest News

Wilkins Ice Shelf under threat

01.12.2008 | Earth Sciences

A picture paints more than a petabyte of data

01.12.2008 | Physics and Astronomy

Sex life of killer fungus finally revealed

01.12.2008 | Life Sciences

Event News

Dublin to host Europe’s largest interdisciplinary science conference in 2012

28.11.2008 | Event News

ECREA Barcelona 2008

28.11.2008 | Event News

The Automobile – The Transition from Energy Guzzler to Power Supplier

20.11.2008 | Event News